Showing results (721-730 of 1,001) with videos related to

Sort By:
Pageof 101
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 29, 2015
A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown LinesMichael A C Kane, Michael H Gold, William P Coleman, et al.
Journal of Clinical Psychology in Medical Settings|November 18, 2020
Predictors of Alcohol Use after Bariatric SurgeryLisa R Miller-Matero, Aaron Hamann, Leah LaLonde, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 6, 2013
Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown linesAlastair Carruthers, Jean Carruthers, William P Coleman, et al.
Research Square|June 9, 2023
NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transportSen Yang, Zhen-Xian Niou, Andrea Enriquez, et al.
Frontiers in Molecular Neuroscience|May 2, 2022
SARM1 Depletion Slows Axon Degeneration in a CNS Model of Neurotropic Viral InfectionColin L Crawford, Christina Antoniou, Lina Komarek, et al.
Molecular Neurodegeneration|January 28, 2024
NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transportSen Yang, Zhen-Xian Niou, Andrea Enriquez, et al.
Pharmaceutical Research|March 4, 2015
EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer TherapySrinivas Ganta, Amit Singh, Praveen Kulkarni, et al.
British Journal of Cancer|June 12, 2014
No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trialsM E Abdel-Rahman, J Butler, M R Sydes, et al.
Health Statistics Quarterly|June 10, 2010
Survival from twenty adult cancers in the UK and Republic of Ireland in the late twentieth centuryLaura M Woods, Bernard Rachet, Lorraine Shack, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 26, 2010
12-Month controlled study in the United States of the safety and efficacy of a permanent 2.5% polyacrylamide hydrogel soft-tissue fillerRhoda S Narins, William P Coleman, Rodney Rohrich, et al.
Pageof 101